VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS

  • US 20180161344A1
  • Filed: 02/09/2018
  • Published: 06/14/2018
  • Est. Priority Date: 10/22/2014
  • Status: Active Application
First Claim
Patent Images

1. A method for treating VVA in a subject, the method comprising:

  • administering, by inserting into the vagina of the subject, a dosage form comprising a liquid pharmaceutical composition, wherein the composition comprises estrogen as the only active agent, and wherein the dosage form dissolves and at least 80% of the composition is absorbed by the vaginal tissue with no vaginal discharge of the composition.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×